Sonnet biotherapeutics provides 2021 business update

Princeton, nj / accesswire / march 29, 2021 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today a business update on its ongoing programs. "last year we continued execution across our pipeline, and i am excited to share an update on our ongoing activities," commented pankaj mohan, ph.d.
SONN Ratings Summary
SONN Quant Ranking